Hospira Logo (Cytarabine 01)
Cytarabine Injection, Solution
Product Images NDC 61703-303
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cytarabine (NDC 61703-303). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Structural Formula Cytarabine Injection (Cytarabine 02)
Hospira Logo (Cytarabine 03)
Principal Display Panel (50 mL Vial Label)
Principal Display Panel (50 mL Vial Carton)
The text appears to be a label of a Cytotoxic Agent, specifically Cytarabine Injection with a dosage format of 1000 mg/50mL. The label warns that it is not for direct infusion and recommends that the dosage format be followed accurately. The brand name of the drug is Hospira and the package is not for sale directly to patients. There are also some additional details about the storage of the drug.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
